Document is current
Any future updates will be listed below
-
Authors
Liddicoat, Johnathon Edward
Lenarczyk, Gabriela
Aboy, Mateo
Minssen, Timo
Porsdam Mann, Sebastian
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF23SA0087056, NNF23SA0087056, NNF23SA0087056, NNF23SA0087056, NNF23SA0087056)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 8 January 2025
First Online: 15 January 2025
Competing interests
: S.P.M. is a member of the ethics advisory board for Retroviral Therapeutics LLC. He is also a member of the advisory board for AminoChain Inc. Prof. Minssen serves as a Member of WHO Committees in Digital Health. Outside the submitted work, he reports personal fees as a former member of the IP Advisory Board at Christian Hansen A/S (now Novonesis); as an expert advisor to Microsoft and Daiki, a company engaged in AI compliance and governance; and as a Senior Advisor at the law firm X officio Advokat AB. J.E.L., G.L., and M.A. declare no competing interests.
